BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Sabin Vaccine Institute Sends 640+ Investigational cAd3-Marburg Vaccine Doses to Ethiopia for Rapid Outbreak Response

The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s res...

December 08, 2025 | News

Replicate Bioscience Partners With Instituto Butantan To Advance Next Generation srRNA Rabies Vaccine Across Latin America

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunol...

December 05, 2025 | News

Kelun Biotech And Crescent Biopharma Forge Global Partnership To Advance Next Generation Oncology Therapies

Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets an...

December 05, 2025 | News

AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...

December 04, 2025 | News

GC Biopharma Achieves WHO Recognition for MAV Zero Six Varicella Vaccine Strain

Officially recognized by WHO as a standard varicella vaccine strain alongside Oka Interchangeability endorsed, enhancing global supply securit...

December 03, 2025 | News

IDEAYA Moves IDE034 Into Clinic Following FDA Clearance and Strong B7H3 PTK7 Co Expression

B7H3 and PTK7 is co-expressed in multiple solid tumor types, including lung, colorectal, and head and neck cancers, at approximately 30%, 46%, and 27%, r...

December 02, 2025 | News

HKeyBio Expands Its Autoimmune and Allergy R&D Capabilities With HKEY-AIDMD 3.0 Platform Upgrade

The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBi...

November 28, 2025 | News

Teijin Pharma to Receive $5M Milestone as Bioprojet Advances Novel Narcolepsy Candidate to Phase 1

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that it will receive in Q4 2025 a milestone paym...

November 28, 2025 | News

Zydus and RK Pharma Partner on Innovative Sterile Injectable for Oncology Supportive Care

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, announced that it has entered into an e...

November 27, 2025 | News

mAIbe and LenioBio Form Strategic Partnership to Accelerate Next-Gen Antibody Discovery

mAIbe and LenioBio are pleased to announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation...

November 27, 2025 | News

eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing

eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, throug...

November 27, 2025 | News

Innova Therapeutics Acquires Enci Therapeutics To Advance First in Class SFRP2 Antibody IVT8086 for Solid and Haematological Cancers

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is exp...

November 26, 2025 | News

Harbour BioMed Deepens Global Collaboration with AstraZeneca to Advance Next Generation Biotherapeutics

Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ...

November 25, 2025 | News

HoneyNaps Drives Faster Clinical Trials with FDA Cleared AI Sleep Analysis Platform

Enhancing Clinical Efficiency with AI Sleep Analysis: Cutting Both Cost and Time Joint Clinical Studies with CROs: SOMNUM™ AI Sleep Scoring D...

November 25, 2025 | News

Stay Connected